Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding

Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15–18 Months of Age in Mexico

(2017) Flor Irene Rodriguez Melo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

(2015) Sri Rezeki Hadinegoro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

(2015) Luis Villar et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers

(2015) Denis Crevat et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study

(2015) Joseph Torresi et al.   VACCINE

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico

(2014) Gustavo H Dayan et al.   Human Vaccines & Immunotherapeutics

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development

(2013) Tatyana M. Timiryasova et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA

(2013) Gustavo H. Dayan et al.   VACCINE

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore

(2013) Anke Harenberg et al.   Human Vaccines & Immunotherapeutics

Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru

(2012) Claudio F. Lanata et al.   VACCINE

Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans

(2011) Ming Qiao et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Interference and Facilitation Between Dengue Serotypes in a Tetravalent Live Dengue Virus Vaccine Candidate

(2011) K. B. Anderson et al.   JOURNAL OF INFECTIOUS DISEASES

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines

(2011) Rosario Z. Capeding et al.   VACCINE

Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue

(2011) Vianney Tricou et al.   PLoS Neglected Tropical Diseases

Detection of Yellow Fever 17D Genome in Urine

(2010) C. Domingo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults

(2010) Dennis Morrison et al.   JOURNAL OF INFECTIOUS DISEASES

Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City

(2010) Jorge Poo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever–dengue vaccines

(2008) N. Mantel et al.   JOURNAL OF VIROLOGICAL METHODS

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects

(2008) Bruno Guy et al.   VACCINE

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

(2008) John T. Roehrig et al.   VIRAL IMMUNOLOGY